← Back to Search

Procedure

Lung Ultrasound vs Chest X-ray for Collapsed Lung (LUSvsCXR Trial)

N/A
Recruiting
Led By Jacobo Moreno Garijo, MD
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Cardiac and trauma patients who have had a chest/mediastinal tube removed within the past two hours in the CVICU, trauma bay, or ward.
Age ≥ 18 years old.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months (full pilot trial)
Awards & highlights

LUSvsCXR Trial Summary

This trial seeks to compare the accuracy of lung ultrasound to standard chest X-rays in diagnosing pneumothorax (a critical condition) after chest tube removal in cardiac and trauma patients.

Who is the study for?
This trial is for adults over 18 who've had a chest tube removed recently after cardiac surgery or trauma. It's not for those with prior pneumothorax needing intervention, on ventilators, or with subcutaneous emphysema affecting ultrasound visibility.Check my eligibility
What is being tested?
The study compares lung ultrasound (LUS) to chest X-rays (CXR) in detecting pneumothorax after chest tube removal. Medical trainees will perform LUS to see if it's more accurate and reliable than the traditional CXR method.See study design
What are the potential side effects?
Lung ultrasounds are generally safe; they may be less uncomfortable than X-rays since they don't involve radiation exposure. However, there might be minor discomfort from the pressure of the ultrasound probe.

LUSvsCXR Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I recently had a chest tube removed.
Select...
I am 18 years old or older.

LUSvsCXR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months (full pilot trial)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months (full pilot trial) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence to LUS Scan Protocol
Feasibility of Accurate LUS Data Collection for Comparison with Chest X-rays
Recruitment rate
Secondary outcome measures
Compare novice-performed LUS with CXR reports performed by experienced radiologists.
Diagnostic Sensitivity of CXR vs LUS
Diagnostic accuracy of LUS vs CXR
+2 more

LUSvsCXR Trial Design

1Treatment groups
Experimental Treatment
Group I: Diagnostic modalities comparisonExperimental Treatment1 Intervention
All participants belong to a single arm. A chest X-ray (CXR) and lung ultrasound (LUS) in a predetermined order (CXR followed by LUS), will be performed sequentially for pneumothorax (PNX) detection after chest/mediastinal tube removal. There is no control group or randomization.

Find a Location

Who is running the clinical trial?

Sunnybrook Health Sciences CentreLead Sponsor
656 Previous Clinical Trials
1,551,248 Total Patients Enrolled
Jacobo Moreno Garijo, MDPrincipal InvestigatorSunnybrook Health Sciences Centre
3 Previous Clinical Trials
120 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What specific goals are researchers aiming to accomplish with this medical experiment?

"This 12-month medical trial intends to gauge adherence to the LUS scan protocol. Secondary objectives involve assessing diagnostic accuracy, sensitivity and interrater reliability of chest X-rays (CXR) compared to Lung Ultrasound Scan (LUS). The latter must have an 80% agreement rate when adjudicated by a specialist in order for results to be considered valid."

Answered by AI

Are there any vacancies for individuals to sign up for this clinical trial?

"According to clinicaltrials.gov, this trial is no longer searching for participants since it's last update August 30th 2023. However, 16 other studies are actively seeking candidates at the moment."

Answered by AI
~28 spots leftby Nov 2024